The long-standing commercial CAR-T players must unite with the hottest trailblazing industry pioneers to shape and secure the future of cell therapy.
The 7th CAR-TCR Summit returns to Boston in 2022 in person with one goal: to engineer a disease-free world.
Across 4 days of carefully curated sessions, we will gather with 200+ CAR and TCR cell therapy VIPs that will lead you and your peers in discussions about novel allogeneic
approaches with enhanced safety considerations, the latest in vivo gene engineering techniques, and advances in CMC strategies and analytical development to ensure the development of high-quality cell products.

PathoQuest is partnering with the CAR-TCR Summit, with the crème de la crème of cell therapy development to discuss, learn from industry successes and pitfalls, and manufacturing automation innovations for large
scale consistent production.

Our NGS dedicated team will be there on BOOTH E87 to help you define your best biosafety strategy.